查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722713

2025 年至 2033 年腫瘤學體內 CRO 市場報告，按適應症（血癌、實體瘤等）、模型（同基因、異種移植、患者來源異種移植 (PDX) 等）、應用（醫院、復健中心）和地區分類

Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2024 年，全球基於腫瘤的體內 CRO 市場規模達到 13 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 24 億美元，2025-2033 年期間的成長率 (CAGR) 為 6.55%。癌症發病率的上升、法規遵循、技術的持續進步以及個人化醫療需求的激增正在推動市場成長。

腫瘤學是指利用活體組織切片、內視鏡檢查、X光、電腦斷層掃描 (CT)、磁振造影 (MRI)、正子斷層掃描 (PET) 和超音波來研究、診斷和治療癌症的醫學分支。它為患者提供荷爾蒙療法、免疫療法、放射療法和口服療法，以耐受和減輕癌症的副作用。目前，由於合約研究組織 (CRO) 開發了多種用於治療癌症的試驗化合物，全球對基於腫瘤學的體內 CRO 的需求正在增加。

基於腫瘤學的體內CRO市場趨勢：

全球癌症發生率的不斷上升是推動市場發展的關鍵因素之一。此外，全球多個國家的政府都在大力投資研發活動。這一點，加上合約研究組織（CRO）在癌症治療方面的專業知識不斷提高，正在推動市場的成長。此外，操縱脫氧核糖核酸（DNA）和改變生物體特性的基因工程創新也不斷增加。再加上人們對調節細胞增殖、生長和分化的致癌基因研究的日益關注，這對市場產生了積極的影響。除此之外，藥品的廣泛普及以及醫療保健產業的不斷擴張，正在催化全球對基於腫瘤的體內 CRO 的需求。除此之外，與內部研究相比，合約研究組織 (CRO) 提供的成本效益為行業投資者提供了豐厚的成長機會。此外，醫療保健行業也擴大採用遠距醫療和虛擬臨床試驗來確保癌症患者的安全。預計這將促進市場的成長。

本報告回答的關鍵問題

  • 2024 年全球腫瘤體內 CRO 市場規模？ 2025 年至 2033 年期間全球腫瘤體內 CRO 市場的預期成長率為何？
  • 推動全球腫瘤學體內 CRO 市場發展的關鍵因素有哪些？
  • COVID-19 對全球基於腫瘤的體內 CRO 市場有何影響？
  • 根據適應症，全球腫瘤學體內 CRO 市場如何分佈？
  • 根據該模型，全球腫瘤學體內 CRO 市場的分佈如何？
  • 全球腫瘤學體內 CRO 市場的關鍵區域有哪些？
  • 全球腫瘤學體內 CRO 市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球腫瘤學體內CRO市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依指標

  • 血癌
  • 實體腫瘤
  • 其他

第7章：市場區隔：依模型

  • 同基因
  • 異種移植
  • 患者來源的異種移植（PDX）
  • 其他

第 8 章：市場區隔：按應用

  • 醫院
  • 復健中心

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Champions Oncology Inc.
    • Charles River Laboratories International Inc.
    • Crown Bioscience Inc.
    • Eurofins Scientific
    • Evotec SE
    • ICON Plc
    • Labcorp Drug Development (Laboratory Corporation of America Holdings)
    • Living Tumor Laboratory
    • Taconic Biosciences Inc.
    • The Jackson Laboratory
    • WuXi AppTec
    • Xentech
Product Code: SR112025A5438

The global oncology based in-vivo CRO market size reached USD 1.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.55% during 2025-2033. The rising prevalence of cancer, regulatory compliances, ongoing technological advancements, and the surging demand for personalized medicines are driving the market growth.

Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.

Oncology Based In-Vivo CRO Market Trends:

The growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.

Key Market Segmentation:

Breakup by Indication:

  • Blood Cancer
  • Solid Tumors
  • Others

Breakup by Model:

  • Syngeneic
  • Xenograft
  • Patient Derived Xenograft (PDX)
  • Others

Breakup by Application:

  • Hospitals
  • Rehabilitation Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.

Key Questions Answered in This Report

  • 1.What was the size of the global oncology based in-vivo CRO market in 2024?
  • 2.What is the expected growth rate of the global oncology based in-vivo CRO market during 2025-2033?
  • 3.What are the key factors driving the global oncology based in-vivo CRO market?
  • 4.What has been the impact of COVID-19 on the global oncology based in-vivo CRO market?
  • 5.What is the breakup of the global oncology based in-vivo CRO market based on the indication?
  • 6.What is the breakup of the global oncology based in-vivo CRO market based on the model?
  • 7.What are the key regions in the global oncology based in-vivo CRO market?
  • 8.Who are the key players/companies in the global oncology based in-vivo CRO market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Based In-Vivo CRO Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Indication

  • 6.1 Blood Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Solid Tumors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Model

  • 7.1 Syngeneic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Xenograft
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Patient Derived Xenograft (PDX)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Rehabilitation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Champions Oncology Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Charles River Laboratories International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Crown Bioscience Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eurofins Scientific
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Evotec SE
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 ICON Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Living Tumor Laboratory
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Taconic Biosciences Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 The Jackson Laboratory
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Xentech
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2024
  • Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2024
  • Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
  • Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
  • Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million USD), 2025-2033
  • Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
  • Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players